A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : SIVmac / simian immunodeficiency virus

[Related PubMed/MEDLINE]
Total Number of Papers: 133
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   SIVmac  (>> Co-occurring Abbreviation)
Long Form:   simian immunodeficiency virus
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Destabilization of the gut microbiome marks the end-stage of simian immunodeficiency virus infection in wild chimpanzees. ChAdV, Chi-SCV, HIV-1, SIVcpz
2018 Virological characterization of HIV-1 CA-NTD mutants constructed in a virus-lineage reflected manner. CA, HIV-1, NTD
2017 Clues for two-step virion infectivity factor regulation by core binding factor beta. CBFbeta, EIAV, Vif
2017 Natural killer cells migrate into and control simian immunodeficiency virus replication in lymph node follicles in African green monkeys. AGMs, NK, SIVagm
2017 The small-molecule 3G11 inhibits HIV-1 reverse transcription. ---
2015 Lineage-Specific Viral Hijacking of Non-canonical E3Ubiquitin Ligase Cofactors in the Evolution of Vif Anti-APOBEC3 Activity. CRL, CyPA
2014 A first-in-class NAE inhibitor, MLN4924, blocks lentiviral infection in myeloid cells by disrupting neddylation-dependent Vpx-mediated SAMHD1 degradation. NAE
2014 Poly-proline motif in HIV-2 Vpx is critical for its efficient translation. HIV-2, PPM
2013 Evidence for a different susceptibility of primate lentiviruses to type I interferons. CA, HIV-1, HIV-2, Trim5alpha, vDNA, VNCs
10  2013 Gain-of-sensitivity mutations in a Trim5-resistant primary isolate of pathogenic SIV identify two independent conserved determinants of Trim5alpha specificity. ---
11  2013 Inhibition of CUL4A Neddylation causes a reversible block to SAMHD1-mediated restriction of HIV-1. HIV-2
12  2012 Electrostatic potential of human immunodeficiency virus type 2 and rhesus macaque simian immunodeficiency virus capsid proteins. HIV-2, Rh, SIVmac239, SIVsm
13  2012 Role of Human TRIM5alpha in Intrinsic Immunity. CA, HIV, HIV-1, HIV-2, MLV, Rh
14  2011 SIV envelope acquires a nefarious habit. Env
15  2010 Anti-retroviral activity of TRIM5 alpha. CM, HIV-1, Rh, TRIM5 alpha
16  2010 Contribution of RING domain to retrovirus restriction by TRIM5alpha depends on combination of host and virus. AGM, HIV-1
17  2010 Multiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5alpha-mediated restriction. CA, CM, HIV-2, Rh
18  2010 Polyubiquitination of APOBEC3G is essential for its degradation by HIV-1 Vif. HIV-1
19  2009 HIV-1 exploits importin 7 to maximize nuclear import of its DNA genome. EIAV, imp7, RTC
20  2009 Modification of a loop sequence between alpha-helices 6 and 7 of virus capsid (CA) protein in a human immunodeficiency virus type 1 (HIV-1) derivative that has simian immunodeficiency virus (SIVmac239) vif and CA alpha-helices 4 and 5 loop improves replication in cynomolgus monkey cells. CA, CA, HIV-1, HIV-2
21  2007 Simian immunodeficiency virus lentivector corrects human X-linked chronic granulomatous disease in the NOD/SCID mouse xenograft. HSCs, PBSCs, X-CGD
22  2007 Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain. CNS, cPPT, LCMV-GP
23  2006 Construction of gag-chimeric viruses between HIV-1 and SIVmac that are capable of productive multi-cycle infection. HIV-1
24  2006 Generation of simian-tropic HIV-1 by restriction factor evasion. stHIV-1
25  2006 Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals. HIV-1, MLV-N
26  2005 Retrovirus restriction by TRIM5alpha variants from Old World and New World primates. HIV-1, N-MLV
27  2004 Capsid-dependent and -independent postentry restriction of primate lentivirus tropism in rodent cells. ---
28  2004 Clinical latency and reactivation of AIDS-related mycobacterial infections. HIV-1
29  2004 Comprehensive analysis of nef functions selected in simian immunodeficiency virus-infected macaques. MHC-I
30  2004 Differential regulation of human immunodeficiency virus type 2 and simian immunodeficiency virus promoter activity. LTR
31  2004 Macaques infected long-term with attenuated simian immunodeficiency virus (SIVmac) remain resistant to wild-type challenge, despite declining cytotoxic T lymphocyte responses to an immunodominant epitope. CTL, SIV
32  2004 Synthesis and assembly of SIVmac Gag p27 capsid protein cholera toxin B subunit fusion protein in transgenic potato. CTB, DNA, GM1-ELISA
33  2002 Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. ---
34  2002 Live, attenuated simian immunodeficiency virus SIVmac-M4, with point mutations in the Env transmembrane protein intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251. TM
35  2001 Basic amino acid residues in the V3 loop of simian immunodeficiency virus envelope alter viral coreceptor tropism and infectivity but do not allow efficient utilization of CXCR4 as entry cofactor. PBMC
36  2001 Detection of viral RNA in CD4(-)CD8(-) and CD4(-)CD8(+) lymphocytes in vivo in rhesus monkeys infected with simian immunodeficiency virus of macaques. ---
37  2001 Effects of reverse-transcriptase mutations M184V and E89G on simian immunodeficiency virus in Rhesus monkeys. ---
38  2001 In vivo T-lymphocyte activation and transient reduction of viral replication in macaques infected with simian immunodeficiency virus. HIV, SEB
39  2000 Dox-dependent SIVmac with tetracycline-inducible promoter in the U3 promoter region. Dox, HIV-1, LTRs, rtTA
40  2000 Simian immunodeficiency virus evades a dominant epitope-specific cytotoxic T lymphocyte response through a mutation resulting in the accelerated dissociation of viral peptide and MHC class I. ---
41  2000 Simian immunodeficiency virus-specific cytotoxic T lymphocytes and cell-associated viral RNA levels in distinct lymphoid compartments of SIVmac-infected rhesus monkeys. CTL
42  1999 Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys. CTL, HIV-1, MHC, PBL
43  1999 Effect of complement consumption by cobra venom factor on the course of primary infection with simian immunodeficiency virus in rhesus monkeys. CTL, CVF
44  1999 Effects of SIVmac infection on peripheral blood CD4+CD8+ T lymphocytes in cynomolgus macaques. DP
45  1999 High throughput detection of retrovirus-associated reverse transcriptase using an improved fluorescent product enhanced reverse transcriptase assay and its comparison to conventional detection methods. F-PERT, MLV, PoERV, SFV, SMRV
46  1999 Improved Mg2+-based reverse transcriptase assay for detection of primate retroviruses. HIV-1, RT
47  1999 Induction of AIDS in rhesus monkeys by a recombinant simian immunodeficiency virus expressing nef of human immunodeficiency virus type 1. HIV-1
48  1999 Morphological correlates of neurological dysfunction in macaques infected with neurovirulent simian immunodeficiency virus. AIDS, CNS, EP, HIV, MGC
49  1999 Mycobacterium bovis bacille Calmette-Guerin enhances pathogenicity of simian immunodeficiency virus infection and accelerates progression to AIDS in macaques: a role of persistent T cell activation in AIDS pathogenesis. BCG
50  1999 Sequential analysis of apoptosis induction in peripheral blood mononuclear cells and lymph nodes in the early phase of pathogenic and nonpathogenic SIVmac infection. PBMCs
51  1999 The appearance of escape variants in vivo does not account for the failure of recombinant envelope vaccines to protect against simian immunodeficiency virus. ---
52  1998 Administration of recombinant human interleukin 12 to chronically SIVmac-infected rhesus monkeys. NK, rhIL-12
53  1998 Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex. CD, CTLs, MHC, PBMC
54  1998 Fractionator analysis shows loss of neurons in the lateral geniculate nucleus of macaques infected with neurovirulent simian immunodeficiency virus. LGN
55  1998 Nucleotide substitutions in the long terminal repeat are not required for development of neurovirulence by simian immunodeficiency virus strain mac. LTR
56  1998 Replication of human immunodeficiency virus type 1 (HIV-1), simian immunodeficiency virus strain mac (SIVmac) and chimeric HIV-1/SIVmac viruses having env genes derived from macrophage-tropic viruses: an indication of different mechanisms of macrophage-tropism in human and monkey cells. HIV-1
57  1997 High degree of sensitivity of the simian immunodeficiency virus (SIVmac) envelope glycoprotein subunit association to amino acid changes in the glycoprotein 41 ectodomain. ---
58  1997 Immunoglobulin V(H) usage during primary infection of rhesus monkeys with chimeric simian-human immunodeficiency viruses. HIV-1
59  1997 Macaques infected with attenuated simian immunodeficiency virus resist superinfection with virulence-revertant virus. CTL
60  1997 Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: a potential candidate live-attenuated human AIDS vaccine. HIV-1
61  1996 A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. HIV-1, SHIVs
62  1996 Induction of antibodies against SIV antigens after intramuscular nucleic acid inoculation using complex expression constructs. PGK
63  1996 Simian immunodeficiency virus DNA vaccine trial in macaques. ---
64  1996 Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. CTL, HIV-1
65  1995 Bone marrow monocyte/macrophages are an early cellular target of pathogenic and nonpathogenic isolates of simian immunodeficiency virus (SIVmac) in rhesus macaques. SIV
66  1995 Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication. HIV-1, PBMCs
67  1995 In vivo administration of CD4-specific monoclonal antibody: effect on provirus load in rhesus monkeys chronically infected with the simian immunodeficiency virus of macaques. mAb
68  1995 Induction of resistance to 1-beta-D-arabinofuranosylcytosine in human H9 cell line by simian immunodeficiency virus. ara-C, THU
69  1995 Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge. CTL, SIV
70  1994 A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. ---
71  1994 An electron-lucent region within the virion distinguishes HIV-1 from HIV-2 and simian immunodeficiency virus. HIV
72  1994 Early helper T-cell dysfunction in simian immunodeficiency virus but not in human immunodeficiency virus type-2-infected macaques. HIV-2
73  1994 Emergence of antigenic variants of simian immunodeficiency virus (SIVmac) in a seronegative macaque after SIVmac239 infection. PCR
74  1994 Purification and characterization of simian immunodeficiency virus (SIVmac) envelope glycoprotein gp130 from virus-infected cells. SIV
75  1994 Selective amplification of simian immunodeficiency virus genotypes after intrarectal inoculation of rhesus monkeys. LTRs
76  1994 Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism. HIV-1, LTR, PMA, RA
77  1994 The "V3" domain is a determinant of simian immunodeficiency virus cell tropism. ---
78  1993 An epitope on the surface envelope glycoprotein (gp130) of simian immunodeficiency virus (SIVmac) involved in viral neutralization and T cell activation. ---
79  1993 Characterization of B-cell epitopes in the envelope glycoproteins of simian immunodeficiency virus. ---
80  1993 Comparison of serum antibody reactivities to a conformational and to linear antigenic sites in the external envelope glycoprotein of simian immunodeficiency virus (SIVmac) induced by infection and vaccination. ---
81  1993 Differences in the B and T cell immune response to the envelope glycoprotein 130 (gp130) of the macaque strain of simian immunodeficiency virus (SIVmac), induced by immunization of rhesus macaques with virus-derived or vaccinia virus-expressed gp130. gp130
82  1993 Human adenovirus type 5 recombinants expressing simian immunodeficiency virus macaque strain gag antigens. ---
83  1993 Self-limiting infection by int/nef-double mutants of simian immunodeficiency virus. ---
84  1993 Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys. CTLs, PBLs
85  1993 Simian immunodeficiency virus-specific cytotoxic T lymphocytes in rhesus monkeys: characterization and vaccine induction. CTL, MHC, TCR
86  1993 Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus. ---
87  1993 Synthetic peptide in mineral oil adjuvant elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes in rhesus monkeys. ---
88  1993 The NF-kappa B binding site is necessary for efficient replication of simian immunodeficiency virus of macaques in primary macrophages but not in T cells in vitro. NF-kappaB
89  1993 Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases env incorporation into particles and fusogenicity and infectivity. ---
90  1992 Cytotoxic T lymphocyte response against multiple simian immunodeficiency virusA (SIV) proteins in SIV-infected macaques. SIV
91  1992 Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag. p11C
92  1992 Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocytetropic parental virus: pathogenesis of infection in macaques. i.c
93  1992 Detection of simian immunodeficiency virus DNA in macrophages from infected rhesus macaques. ---
94  1992 Elevated vascular cell adhesion molecule-1 in AIDS encephalitis induced by simian immunodeficiency virus. CSF, ICAM-1, VCAM-1
95  1992 Expression of simian immunodeficiency virus (SIVmac) proteinase in E. coli. ---
96  1992 Generation of deletion mutants of simian immunodeficiency virus incapable of proviral integration. IN
97  1992 Genetic and biological comparisons of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac). HIV, SIV
98  1992 Immunogenic peptides corresponding to the dominant antigenic region alanine-597 to cysteine-619 in the transmembrane protein of simian immunodeficiency virus have a propensity to fold in aqueous solution. NOE
99  1992 Potential significance of the cellular immune response against the macaque strain of simian immunodeficiency virus (SIVMAC) in immunized and infected rhesus macaques. CTLs
100  1992 Predominant use of a T-cell receptor V beta gene family in simian immunodeficiency virus Gag-specific cytotoxic T lymphocytes in a rhesus monkey. CTL, TCR